RecruitingNCT07449130

AI Assisted Screening for VHD Using Routine Chest CT Scans

Artificial-Intelligence Assisted Opportunistic Screening for Valvular Heart Disease Using Non-contrast Chest CT Scans: A Prospective, Multicenter Study


Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

3,000 participants

Start Date

Mar 2, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective, multicenter study designed to validate a deep learning model for screening valvular heart diseases using routine, non-contrast chest computed tomography (CT) scans. The primary objective is to evaluate the model's diagnostic performance, with the sensitivity serving as the primary efficacy endpoint. Secondary endpoints will include other performance metrics such as area under the receiver operating characteristic curve (AUC), specificity, and accuracy, etc.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with heart valve diseases. The study is currently recruiting participants at 3 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

Renmin Hospital of Wuhan University

Wuhan, Hubei, China

Xinjiang Uygur Autonomous Region People's Hospital

Ürümqi, Xinjiang, China

The Second Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07449130


Related Trials